634 AAK1 inhibitor LX-9211: Junctional protein 2-associated kinase 1 (AAK1) is widely expressed in the brain and spinal cord and is a viable target for the treatment of neuropathic pain, and BMS-986176/LX-9211 is a novel class of bis(iso)aryl ethers that are highly selective, CNS-permeable, and potent AAK1 inhibitors
Semaglutide (Wegovy) Semaglutide is a weekly injectable GLP-1 receptor agonist
Results are delivered in a clear, actionable report, with a recommended retest cadence of every 60 to 90 days to track progress with time
Reviewing thyroid function, insulin sensitivity, and cortisol can identify a metabolic obstacle that the medication alone is not addressing
Pre-mixed liquid formulations are ready to inject straight from the vial
The choice often comes down to personal needs, lifestyle, and insurance coverage